Figure 4.
Proposed treatment pathway for COPD patients without frequent exacerbations. LABA long acting β2-adrenoceptor agonist; LAMA long acting muscarinic antagonist; FDC fixed dose combination; FEV1 forced expiratory volume in 1 s.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.